Myomo (NYSEAMERICAN:MYO) Stock Breaks Below Fifty Day Moving Average – Time to Sell?

Myomo, Inc. (NYSEAMERICAN:MYO) shares crossed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $1.38 and traded as low as $1.22. Myomo shares last traded at $1.27, with a volume of 498,523 shares.

Myomo News Roundup

Here are the key news stories impacting Myomo this week:

• Positive Sentiment: Q3 revenue increased 22.2% year over year to $12.3 million, exceeding analyst expectations, while gross profit rose 36.4% to $8.8 million. The company also reported breakeven adjusted EBITDA, signaling improved operating leverage. Myomo Q3 results
• Positive Sentiment: Myomo set 2026 revenue guidance at $46 million–$47 million, above the $45.5 million consensus estimate, and expects modest sequential gross-margin improvement in Q4. Its reported Q3 loss of $0.07 per share was also narrower than the $0.08 loss analysts expected. Myomo updates revenue outlook
• Negative Sentiment: The business remains unprofitable: a third-party results summary cited a $4.2 million net loss and $1.3 million in operating cash outflow for the quarter. Myomo ended Q3 with $11.1 million in cash and $31.1 million in liabilities, keeping execution and financing needs in focus. Myomo Q3 financial summary

Myomo Price Performance

The stock has a 50 day moving average of $1.38 and a two-hundred day moving average of $1.09. The company has a debt-to-equity ratio of 1.98, a quick ratio of 2.01 and a current ratio of 2.31. The firm has a market capitalization of $50.30 million, a P/E ratio of -3.63 and a beta of 1.74.

Myomo (NYSEAMERICAN:MYO) last posted its earnings results on Monday, November 9th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.01. The firm had revenue of $12.33 million during the quarter, compared to analyst estimates of $11.51 million. Myomo had a negative return on equity of 152.04% and a negative net margin of 33.14%. Sell-side analysts predict that Myomo, Inc. will post -0.32 earnings per share for the current fiscal year.

Insider Activity at Myomo

In other news, insider Harry Kovelman sold 17,250 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $1.73, for a total value of $29,842.50. Following the completion of the sale, the insider directly owned 105,983 shares in the company, valued at approximately $183,350.59. The trade was a 14.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold a total of 47,738 shares of company stock valued at $70,662 over the last 90 days. Company insiders own 12.14% of the company’s stock.

Myomo Company Profile

Myomo, Inc. is a medical device company that develops and markets wearable robotic braces designed to help individuals with impaired upper-limb function regain movement and perform activities of daily living. Its principal product is the MyoPro, a lightweight, electrically powered orthosis that detects a user’s residual muscle signals and assists movement of the arm and hand. The MyoPro is intended for people affected by neuromuscular disorders and injuries, including stroke, brachial plexus injury, multiple sclerosis, traumatic brain injury and spinal cord injury.